|
|
|
Volumn 18, Issue 14 Suppl 12, 2004, Pages 13-16
|
|
Gemcitabine and docetaxel in metastatic breast cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
DEOXYCYTIDINE;
DOCETAXEL;
DRUG DERIVATIVE;
GEMCITABINE;
TAXOID;
BREAST TUMOR;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
REVIEW;
TIME;
TREATMENT OUTCOME;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DEOXYCYTIDINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
TAXOIDS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 15544364387
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (21)
|
